Breaking News
19 hours ago
Simantini Singh Deo

A $1.1B funding wave across 34 rounds is consolidating automated cell therapy GMP platforms around Cellares and Ori Biotech.
Simantini Singh Deo

Alembic Pharma gains USFDA tentative approval for Binimetinib 45 mg as sole first applicant, opening a potential 180-day generic exclusivity window.
Simantini Singh Deo

Zydus Lifesciences acquires Assertio, making it a wholly owned subsidiary and expanding its US specialty pharma footprint under direct FDA oversight.
Simantini Singh Deo

Sanofi's Sarclisa SC gains Japan approval for multiple myeloma; CirCLIQ on-body injector application remains under review.
Vaibhavi M.
